(Q42499019)

1 November 2017

title

Preventive effects of curcumin on the development of azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db obese mice (English)

1 reference

1 November 2017

0 references

0 references

9

Takuji Tanaka

1 reference

1 November 2017

Masaya Kubota

1

1 reference

1 November 2017

Masahito Shimizu

2

1 reference

1 November 2017

Hiroyasu Sakai

3

1 reference

1 November 2017

Yoichi Yasuda

4

1 reference

1 November 2017

Daishi Terakura

5

1 reference

1 November 2017

Atsushi Baba

6

1 reference

1 November 2017

Tomohiko Ohno

7

1 reference

1 November 2017

Hisashi Tsurumi

8

1 reference

1 November 2017

Hisataka Moriwaki

10

1 reference

1 November 2017

publication date

15 December 2011

1 reference

1 November 2017

1 reference

1 November 2017

volume

64

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

72-79

1 reference

Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Obesity, the PI3K/Akt signal pathway and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Enhancement of development of azoxymethane-induced colonic premalignant lesions in C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Tumour necrosis factor-alpha as a tumour promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Regulation of COX and LOX by curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Dietary curcumin significantly improves obesity-associated inflammation and diabetes in mouse models of diabesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Pre-cancerous lesions for colorectal cancers in rodents: a new concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Limited effects of dietary curcumin on Th-1 driven colitis in IL-10 deficient mice suggest an IL-10-dependent mechanism of protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Control of cyclooxygenase-2 transcriptional activation by pro-inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Energy homeostasis and cancer prevention: the AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Adiponectin as an anti-inflammatory factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Leptin is a growth factor for colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Leptin promotes motility and invasiveness in human colon cancer cells by activating multiple signal-transduction pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F01635581.2012.630554

10.1080/01635581.2012.630554

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference